CCND1 and non-small cell lung carcinoma: Overexpression of the CDK4/6 partner cyclin D1 has been identified in a number of tumor types [14,15,18], such as mantle cell lymphoma (with a well-known translocation involving cyclin D1 in nearly 100% of these cases), non-small cell lung cancer, and breast cancer.